Acutaas Chemicals Reports Strong Growth Amid Recent Sales Decline and Financial Adjustments
Acutaas Chemicals, a midcap in the Pharmaceuticals & Biotechnology sector, has experienced notable financial shifts, with significant growth in profit after tax and net sales over the past six months. However, recent quarterly results show a decline in net sales and profit before tax, despite a stable financial structure and increased institutional holdings.
Acutaas Chemicals, a midcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an evaluation adjustment that reflects notable shifts in its financial metrics. The company's financial performance for the quarter ending June 2025 has been characterized by significant growth, with a profit after tax (PAT) of Rs 106.77 crore, marking a substantial increase of 171.49% over the last six months. Additionally, net sales for the same period reached Rs 515.72 crore, demonstrating a growth rate of 28.41%.However, the latest quarterly results indicate a decline in net sales, which stood at Rs 207.24 crore, a decrease compared to the previous four-quarter average. Similarly, profit before tax (PBT) less other income for the quarter was reported at Rs 42.14 crore, also reflecting a decline against the previous average.
Despite these fluctuations, Acutaas Chemicals has maintained a low debt-to-equity ratio of 0.06 times, indicating a stable financial structure. The company has consistently reported positive results over the last four quarters, and its institutional holdings have increased by 4.52% in the previous quarter, suggesting confidence from larger investors.
Overall, the recent evaluation adjustment highlights the dynamic nature of Acutaas Chemicals' financial landscape, influenced by both strong growth metrics and recent quarterly performance trends.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
